Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Cronos Group Inc.

CRONNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$2.64
$-0.06(-2.22%)
U.S. Market opens in 12h 15m

Cronos Group Inc. Fundamental Analysis

Cronos Group Inc. (CRON) shows moderate financial fundamentals with a PE ratio of 28.34, profit margin of 27.27%, and ROE of 3.36%. The company generates $0.1B in annual revenue with strong year-over-year growth of 35.01%.

Key Strengths

Cash Position81.02%
PEG Ratio0.35
Current Ratio22.45

Areas of Concern

ROE3.36%
Operating Margin-16.07%
We analyze CRON's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 68.3/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
68.3/100

We analyze CRON's fundamental strength across five key dimensions:

Efficiency Score

Weak

CRON struggles to generate sufficient returns from assets.

ROA > 10%
3.06%

Valuation Score

Moderate

CRON shows balanced valuation metrics.

PE < 25
28.34
PEG Ratio < 2
0.35

Growth Score

Moderate

CRON shows steady but slowing expansion.

Revenue Growth > 5%
35.01%
EPS Growth > 10%
1.58%

Financial Health Score

Excellent

CRON maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
22.45

Profitability Score

Weak

CRON struggles to sustain strong margins.

ROE > 15%
3.36%
Net Margin ≥ 15%
27.27%
Positive Free Cash Flow
No

Key Financial Metrics

Is CRON Expensive or Cheap?

P/E Ratio

CRON trades at 28.34 times earnings. This indicates a fair valuation.

28.34

PEG Ratio

When adjusting for growth, CRON's PEG of 0.35 indicates potential undervaluation.

0.35

Price to Book

The market values Cronos Group Inc. at 0.95 times its book value. This may indicate undervaluation.

0.95

EV/EBITDA

Enterprise value stands at 87.05 times EBITDA. This signals the market has high growth expectations.

87.05

How Well Does CRON Make Money?

Net Profit Margin

For every $100 in sales, Cronos Group Inc. keeps $27.27 as profit after all expenses.

27.27%

Operating Margin

Core operations generate -16.07 in profit for every $100 in revenue, before interest and taxes.

-16.07%

ROE

Management delivers $3.36 in profit for every $100 of shareholder equity.

3.36%

ROA

Cronos Group Inc. generates $3.06 in profit for every $100 in assets, demonstrating efficient asset deployment.

3.06%

Following the Money - Real Cash Generation

Operating Cash Flow

Cronos Group Inc. produces operating cash flow of $21.62M, showing steady but balanced cash generation.

$21.62M

Free Cash Flow

Cronos Group Inc. generates weak or negative free cash flow of $-5.70M, restricting financial flexibility.

$-5.70M

FCF Per Share

Each share generates $-0.01 in free cash annually.

$-0.01

FCF Yield

CRON converts -0.56% of its market value into free cash.

-0.56%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

28.34

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.35

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.95

vs 25 benchmark

P/S Ratio

Price to sales ratio

7.68

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.002

vs 25 benchmark

Current Ratio

Current assets to current liabilities

22.45

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.03

vs 25 benchmark

ROA

Return on assets percentage

0.03

vs 25 benchmark

ROCE

Return on capital employed

-0.02

vs 25 benchmark

How CRON Stacks Against Its Sector Peers

MetricCRON ValueSector AveragePerformance
P/E Ratio28.3429.28 Neutral
ROE3.36%820.00% Weak
Net Margin27.27%-19731.00% (disorted) Strong
Debt/Equity0.000.26 Strong (Low Leverage)
Current Ratio22.454.69 Strong Liquidity
ROA3.06%-17993.00% (disorted) Weak

CRON outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Cronos Group Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

355.08%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-96.76%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

113.00%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ